L-selectin is the key factor controlling binding of B-cell CLL cells to high endothelial venule (HEV) walls of lymph nodes in vivo, which is related to cell growth and drug resistance of CLL (107). This evidence concerns the gene SELL and B-cell chronic lymphocytic leukemia.